Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breakthrough Pain × Morphine × Clear all

Phase

Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colonic Neoplasms 3 Chronic Pain 3 Cancer Pain 3 Supratentorial Neoplasms 2 Pain, Postoperative 2 Neoplastic Cells, Circulating 2 Neoplasms 2 Colorectal Neoplasms 2 Substance Withdrawal Syndrome 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pain 1 Neoplasm, Residual 1 Nalbuphine Allergy 1 Ileus 1 Head and Neck Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Breakthrough Pain 1 Brain Neoplasms 1 Agnosia 1 Age Problem 1 Abdominal Cancer 1

Interventions

Ultracet 1 Morphine 1 Gastrostomy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02869321 2019-05-13

ANTALGIP

Central Hospital, Nancy, France

Phase 4 Completed

Head and Neck Neoplasms, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡